Eden in Delaware

Is Eden legit?

No verdict has been issued yet. This is a neutral factual record. Eden (tryeden.com, also eden.health) is a direct-to-consumer telehealth membership platform operated by Eden Health International Inc., which the FDA's June 2026 warning letter and Eden's BBB profile both list at 110 16th St Ste 1431, Denver, CO 80202; Eden's Terms of Service separately list a Wilmington, Delaware address, consistent with a registered-agent filing address rather than an operating office. Eden sells compounded semaglutide ($99/mo) and compounded tirzepatide ($199/mo), plus brand-name Ozempic, Wegovy, Zepbound, and Mounjaro at list price (roughly $1,399-$1,695/mo), all gated behind a required $39-first-month/$99-per-month-thereafter membership. On the specific lead this record was built to verify: multiple third-party affiliate/review sites (healingmaps.com, therxindex.com, and others) report that Eden "paused its compounded GLP-1 program for new patient enrollment as of mid-2026." That claim is NOT supported by a direct check of Eden's own live site on the access date below - as of 2026-07-12, tryeden.com's own homepage banner reads "Compounded semaglutide for $99/mo, free expedited shipping on all orders," the eden.health/weight-loss page actively lists both compounded semaglutide and compounded tirzepatide with working "Get started" checkout links, and Eden's own intake flow (app.eden.health/intake/weightloss/welcome) is live and accepting new-patient intake with no waitlist, closed-enrollment, or paused-program notice anywhere in the page. One of the affiliate sources making the pause claim (therxindex.com) also uses the same page to steer readers toward a competitor ("the closest replacement we'd check next is Embody") - a pattern consistent with affiliate-marketing content rather than a verified operational fact. It is possible the reports reflect a temporary pause that has since lifted, or confusion with Eden's June 8, 2026 FDA warning letter, but no primary source (news outlet, regulator, or Eden's own site) was located that documents an actual enrollment pause; the balance of direct evidence indicates the compounded GLP-1 program is currently open to new patients. Eden's own About page names four fulfillment pharmacies (GoGoMeds, Precision, Enovex, AbsolutePharmacy) and states its combined pharmacy/provider network serves all 50 states and DC. Eden received an FDA warning letter (June 8, 2026, MARCS-CMS 728279) for website claims that made Eden appear to be the compounder of its own semaglutide/tirzepatide products and for describing its compounding sources as "FDA-licensed 503(a) outsourcing facilities" (a designation the FDA says does not exist) - a concern signal about labeling/marketing accuracy, not a shutdown order. Eden also carries an F rating and BBB Pattern-of-Complaints alert with 102 filed complaints and no response to 78 of them. Founding date and any parent company beyond Eden Health International Inc. itself are not disclosed in the sources reviewed. No news coverage of a lawsuit or state attorney-general action specific to Eden's GLP-1 business was located as of the access date.

Is Eden's pharmacy licensed in Delaware?

Fills through Boothwyn, Midtown Express +1 per market data — pharmacies we haven't profiled, so nothing verified in Delaware.

Does Eden ship to Delaware?

Delaware is on Eden's ship-to list on our record (50 states, last reviewed 2026-07-12).

How much does Eden cost?

Compounded tirzepatide from $306/mo (monthly plan); Compounded semaglutide from $196/mo (monthly plan) — observed market pricing, snapshot 2026-07-20.